Brian A Ference, MD, MPhil, MSc, FACC, FESC

Professor Brian A Ference

Disclosure details

Research Grants: Merck, Novartis, Amgen, Esperion Therapeutics, Ionis Pharmaceuticals Consulting Fees, Advisory Boards, Honoraria: Merck, Amgen, Regeneron, Sanofi, Novartis, Pfizer, Eli Lilly, Novo Nordisk, The Medicines Co, Mylan, Daiichi Sankyo, Silence Therapeutics, Ionis Pharmaceuticals,, dalCOR, CiVi Pharma, Dr Reddy’s, KrKa Phamaceuticals, Medtronic, American College of Cardiology, European Atherosclerosis Society, European Society of Cardiology

Professor and Director of Research in Translational Therapeutics, and Head of the Centre for Naturally Randomized Trials at the University of Cambridge, UK

Please login or create a FREE account to view this content

E-mail Address

Password

Only fill in if you are not human

Keep me signed in

Register

Forgot your password?